NTAP(NTAP)
NTAP
Q3 2026 EPS Estimate
$2.11
Sep 2, 2026 · Reports after close
Revenue Estimate
$1.83B
FY2027E EPS$8.91
FY2028E EPS$9.84
Analyst Sentiment
Wall St. Consensus
Hold21 analysts·High coverage
60
Score
10 Buy (48%)9 Hold (43%)2 Sell (9%)
Rating Breakdown
Strong Buy
00%
Buy
1048%
Hold
943%
Sell
210%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$150.00
-27.1%
Consensus
$173.00
-15.9%
Bull
$200.00
-2.7%
12-Month Target Range21 analysts
$150.00$173.00$200.00
Current $205.65Consensus
Current Price
$205.65
Above Consensus
$32.65
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+9.22%
EPS+11.60%
FY2028
Rev+5.46%
EPS+10.50%
FY2029
Rev+5.06%
EPS+6.90%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $7.48B | $7.89B | $8.29B |
| Low | $7.44B | $7.62B | $8.10B |
| High | $7.59B | $8.32B | $8.54B |
| EBITDA Avg | $1.84B | $1.94B | $2.04B |
| Low | $1.83B | $1.87B | $1.99B |
| High | $1.87B | $2.05B | $2.10B |
| EBIT Avg | $1.56B | $1.65B | $1.73B |
| Low | $1.55B | $1.59B | $1.69B |
| High | $1.59B | $1.74B | $1.78B |
| Net Income Avg | $1.78B | $1.90B | $2.11B |
| Low | $1.76B | $1.83B | $2.04B |
| High | $1.80B | $2.09B | $2.18B |
| EPS Avg | $8.91 | $9.84 | $10.52 |
| Low | $8.86 | $9.19 | $10.24 |
| High | $9.04 | $10.50 | $10.94 |
| Analysts (Rev / EPS) | 14 / 12 | 14 / 12 | 5 / 1 |
Quarterly
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 | Q3 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.83B | $1.84B | $1.98B | $1.85B | $1.95B | $1.98B | $2.11B | $1.93B |
| Low | $1.78B | $1.78B | $1.92B | $1.79B | $1.89B | $1.92B | $2.04B | $1.87B |
| High | $1.88B | $1.88B | $2.03B | $1.89B | $2.00B | $2.03B | $2.16B | $1.98B |
| EBITDA Avg | $450M | $451M | $486M | $455M | $480M | $488M | $519M | $475M |
| Low | $438M | $437M | $471M | $440M | $465M | $473M | $503M | $460M |
| High | $463M | $462M | $498M | $466M | $491M | $500M | $532M | $487M |
| EBIT Avg | $383M | $383M | $413M | $386M | $408M | $415M | $441M | $404M |
| Low | $372M | $372M | $400M | $374M | $395M | $402M | $427M | $391M |
| High | $393M | $393M | $424M | $396M | $418M | $425M | $452M | $414M |
| Net Income Avg | $428M | $439M | $483M | $434M | $478M | $501M | $557M | $458M |
| Low | $404M | $422M | $464M | $417M | $458M | $481M | $534M | $439M |
| High | $455M | $453M | $499M | $448M | $493M | $517M | $575M | $473M |
| EPS Avg | $2.15 | $2.21 | $2.43 | $2.18 | $2.40 | $2.52 | $2.80 | $2.30 |
| Low | $2.03 | $2.12 | $2.33 | $2.09 | $2.30 | $2.42 | $2.69 | $2.21 |
| High | $2.29 | $2.28 | $2.51 | $2.25 | $2.48 | $2.60 | $2.89 | $2.37 |
| Analysts (Rev / EPS) | 11 / 12 | 5 / 10 | 8 / 10 | 5 / 10 | 5 / 10 | 5 / 6 | 8 / 6 | 4 / 6 |